Results 61 to 70 of about 9,581 (161)

Effect of montelukast on remission maintenance in patients with ulcerative colitis: a Randomized, double-blind controlled clinical trial

BMC Gastroenterology
Background Considering the role of leukotrienes in inflammatory pathways, and owing to the anti-leukotrienes effect of montelukast, in the present clinical trial, we aimed to assess the effect of montelukast on remission maintenance in patients with ...
Kourosh Masnadi Shirazi, Mehran Nezam Diba, Arman Masnadi Shirazinezhad, Zeinab Nikniaz   +3 more
doaj   +1 more source

Inhibition of leukotrienes and their potential role in type 1 diabetes pathogenesis: implications for montelukast as a therapeutic agent: a case report

Frontiers in Clinical Diabetes and Healthcare
IntroductionType 1 diabetes involves immune-mediated destruction of insulin-producing beta cells, with eosinophils potentially playing a significant role. Recent studies suggest that leukotriene inhibition might influence this process.
Pavel Fatulla, Pavel Fatulla, Ingela Ström, Christine Lingblom, Christine Lingblom, Marcus Lind, Marcus Lind, Marcus Lind   +7 more
doaj   +1 more source

Montelukast alleviates neuroinflammation and improves motor functions in the line 61 model of Parkinson's disease: An exploratory study

Neurotherapeutics
Parkinson's disease (PD) is a neurodegenerative movement disorder of high global burden. Uncertainties regarding its exact etiology have been hindering the development of curative therapies.
Katharina Strempfl, Marco Zattoni, Heike Mrowetz, Michael S. Unger, Nikolaos Schörghofer, Barbara Altendorfer, Jörg Neddens, Stefanie Flunkert, Birgit Hutter-Paier, Yachao He, Johan Wallin, Rodolphe W. Poupardin, Frank Pietrantonio, Nadine Paiement, Horst Zerbe, Thomas Felder, Per Svenningsson, Ludwig Aigner   +17 more
doaj   +1 more source

Risk of neuropsychiatric adverse events associated with montelukast use in children and adolescents: a population-based case-crossover study

BMJ Paediatrics Open
Purpose Montelukast is used extensively in children and adolescents for allergic rhinitis and asthma. However, concerns have been raised regarding the increased risk of neuropsychiatric adverse events (NPAEs) associated with montelukast use.
Ju-Young Shin, Jae Won Kim, Mideum Kim, Min Sook Seo   +3 more
doaj   +1 more source

Montelukast Prescription Prevalence and Impact on Clinical Outcomes Among Patients with Asthma: A Cross-Sectional Study in Saudi Arabia

Journal of Asthma and Allergy
Abdullah A AlqarniAbdulelah M AldhahirRayan A SirajJaber S AlqahtaniRose M AlghamdiThuraya A BaqaisNorah A NajraniAsma Z AlbarqiAhmed H AlasimiHassan AlwafiDepartment of Respiratory Therapy, Faculty of Medical Rehabilitation Sciences, King Abdulaziz ...
Alqarni AA, Aldhahir AM, Siraj RA, Alqahtani JS, Alghamdi RM, Baqais TA, Najrani NA, Albarqi AZ, Alasimi AH, Alwafi H   +9 more
doaj  

The Efficacy of Montelukast Monotherapy in Moderate Persistent Asthmatic Children

Iranian Journal of Allergy, Asthma and Immunology, 2009
Although current guidelines place single leukotriene receptor antagonists use as a therapeutic option in mild persistent asthma, there is still uncertainty about its place.
Mahir Igde, Fehim Yasar Anlar
doaj  

Effectiveness of Montelukast in Reducing the Risk of Severe Dengue in Dengue Fever Patients: An Evidence-Based Case Report

Acta Medica Indonesiana
Background: Dengue fever continues to spread worldwide, particularly in tropical regions. Some patients with dengue fever may progress to severe dengue, which is associated with significantly higher morbidity and mortality.
Nicholas Jason Wijaya, Sharifah Shakinah, Leonard Nainggolan, Erni Juwita Nelwan   +3 more
doaj   +2 more sources

Salivary Cortisol versus Serum Cortisol Levels in Asthmatic Children Treated with Inhaled Corticosteroid Alone or in Combination with Montelukast. [PDF]

J Asthma Allergy
AbdulWahab A, Alsiddig RAA, Al-Naimi A, Maarafiya M, Abushahin A, Hani Y, Singh R, Jerobin J, Bettahi I, Abu-Hasan M.   +9 more
europepmc   +1 more source

Gut microbiome shift in long COVID: impact of disease and montelukast treatment. [PDF]

J Glob Health
Camps-Massa P, Pérez-Mormeneu J, Guevara-Nuñez D, Saiz-Escobedo L, Calatayud L, González-Díaz A, Sanllorente A, Vicens-Zygmunt V, Santos S, Morros R, Salvador-González B, Domínguez MÁ, Martí S, E-SPERANZA study group.   +13 more
europepmc   +1 more source

Risk of drug-related aggression in pediatric populations: a pharmacovigilance analysis using the FAERS database. [PDF]

Front Pediatr
Chen J, Zhao L.
europepmc   +1 more source